Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1999;100:2267-2275

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Intengan, H. D.
Right arrow Articles by Schiffrin, E. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Intengan, H. D.
Right arrow Articles by Schiffrin, E. L.

(Circulation. 1999;100:2267.)
© 1999 American Heart Association, Inc.


Basic Science Reports

Resistance Artery Mechanics, Structure, and Extracellular Components in Spontaneously Hypertensive Rats

Effects of Angiotensin Receptor Antagonism and Converting Enzyme Inhibition

Hope D. Intengan, PhD; Gaétan Thibault, PhD; Jin-Sheng Li, MD, PhD; Ernesto L. Schiffrin, MD, PhD, FRCPC

From the MRC Multidisciplinary Research Group on Hypertension, Clinical Research Institute of Montreal, Montreal, Quebec, Canada.

Correspondence to Ernesto L. Schiffrin, MD, PhD, FRCPC, Clinical Research Institute of Montreal, 110 Pine Ave West, Montreal, Quebec, Canada H2W 1R7. E-mail schiffe{at}IRCM.qc.ca

Background—Altered vascular mechanics resulting from changes in collagen and integrins may influence resistance artery structure and function and, therefore, peripheral resistance and blood pressure in spontaneously hypertensive rats (SHR).

Methods and Results—Effects of age, angiotensin-converting enzyme inhibition (fosinopril, 10 to 30 mg/kg per day), and AT1-receptor antagonism (irbesartan, 50 mg/kg per day) on vascular structure, mechanics, and composition were assessed in SHR. Systolic blood pressure was elevated in young SHR (130±2 mm Hg) compared with Wistar-Kyoto (WKY) rats (106±2 mm Hg). In adult SHR, the rise in systolic blood pressure (44±3 mm Hg) was blunted by fosinopril (18±1 mm Hg) and irbesartan (9±3 mm Hg). Lumen diameter of mesenteric resistance arteries was smaller and media/lumen ratio was greater in young and adult SHR versus WKY rats. Growth index was 24% in untreated adult SHR versus WKY rats; these values were -35% for fosinopril-treated and -29% for irbesartan-treated SHR versus untreated SHR. Isobaric wall stiffness was normal despite increased stiffness of wall components in adult SHR vessels. Irbesartan partially prevented stiffening of wall components in SHR. The collagen/elastin ratio was greater in adult SHR vessels (6.5±1.3) than in WKY (3.2±0.4) vessels. Expression of {alpha}vß3 and {alpha}5ß1 integrins was increased in SHR aged 20 versus 6 weeks. Expression of {alpha}5ß1 integrins was lower in young SHR, and {alpha}vß3 integrins were overexpressed in adult SHR versus WKY rats. Irbesartan and fosinopril attenuated differences in the collagen/elastin ratio and integrin expression.

Conclusions—Wall components of mesenteric resistance arteries stiffen with age in SHR. Interrupting the renin-angiotensin system has normalizing effects on integrin expression and composition, stiffness, and growth of the arterial wall.


Key Words: arteries • mechanics • remodeling • collagen • cell adhesion molecules




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Belmadani, M. Zerfaoui, H. A. Boulares, D. I. Palen, and K. Matrougui
Microvessel vascular smooth muscle cells contribute to collagen type I deposition through ERK1/2 MAP kinase, {alpha}v{beta}3-integrin, and TGF-{beta}1 in response to ANG II and high glucose
Am J Physiol Heart Circ Physiol, July 1, 2008; 295(1): H69 - H76.
[Abstract] [Full Text] [PDF]


Home page
Therapeutic Advances in Cardiovascular DiseaseHome page
K. Sonoyama, A. Greenstein, A. Price, K. Khavandi, and T. Heagerty
Review: Vascular remodeling: implications for small artery function and target organ damage
Therapeutic Advances in Cardiovascular Disease, December 1, 2007; 1(2): 129 - 137.
[Abstract] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. E. Mullick, U. B. Zaid, C. N. Athanassious, S. R. Lentz, J. C. Rutledge, and J. D. Symons
Hyperhomocysteinemia increases arterial permeability and stiffness in mice
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2006; 291(5): R1349 - R1354.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. M. Gonzalez, A. M. Briones, B. Somoza, C. J. Daly, E. Vila, B. Starcher, J. C. McGrath, M. C. Gonzalez, and S. M. Arribas
Postnatal alterations in elastic fiber organization precede resistance artery narrowing in SHR
Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H804 - H812.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. M. Briones, F. E. Xavier, S. M. Arribas, M. C. Gonzalez, L. V. Rossoni, M. J. Alonso, and M. Salaices
Alterations in structure and mechanics of resistance arteries from ouabain-induced hypertensive rats
Am J Physiol Heart Circ Physiol, July 1, 2006; 291(1): H193 - H201.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
E. VanBavel and M. J. Mulvany
Integrins in Hypertensive Remodeling
Hypertension, February 1, 2006; 47(2): 147 - 148.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. De Ciuceis, F. Amiri, P. Brassard, D. H. Endemann, R. M. Touyz, and E. L. Schiffrin
Reduced Vascular Remodeling, Endothelial Dysfunction, and Oxidative Stress in Resistance Arteries of Angiotensin II-Infused Macrophage Colony-Stimulating Factor-Deficient Mice: Evidence for a Role in Inflammation in Angiotensin-Induced Vascular Injury
Arterioscler. Thromb. Vasc. Biol., October 1, 2005; 25(10): 2106 - 2113.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Igase, W. B. Strawn, P. E. Gallagher, R. L. Geary, and C. M. Ferrario
Angiotensin II AT1 receptors regulate ACE2 and angiotensin-(1-7) expression in the aorta of spontaneously hypertensive rats
Am J Physiol Heart Circ Physiol, September 1, 2005; 289(3): H1013 - H1019.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
P. Brassard, F. Amiri, and E. L. Schiffrin
Combined Angiotensin II Type 1 and Type 2 Receptor Blockade on Vascular Remodeling and Matrix Metalloproteinases in Resistance Arteries
Hypertension, September 1, 2005; 46(3): 598 - 606.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. Amar, J.-B. Ruidavets, J.-C. Peyrieux, J.-M. Mallion, J. Ferrieres, M. E. Safar, and B. Chamontin
C-Reactive Protein Elevation Predicts Pulse Pressure Reduction in Hypertensive Subjects
Hypertension, July 1, 2005; 46(1): 151 - 155.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. A. Ahimastos, A. K. Natoli, A. Lawler, P. A. Blombery, and B. A. Kingwell
Ramipril Reduces Large-Artery Stiffness in Peripheral Arterial Disease and Promotes Elastogenic Remodeling in Cell Culture
Hypertension, June 1, 2005; 45(6): 1194 - 1199.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. Lehoux and A. Tedgui
Making Up and Breaking Up: The Tortuous Ways of the Vascular Wall
Arterioscler. Thromb. Vasc. Biol., May 1, 2005; 25(5): 892 - 894.
[Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. Miquel, R. Gisbert, E. Serna, F. Perez-Vizcaino, E. Anselmi, M. A. Noguera, M. D. Ivorra, and M. P. D'Ocon
Acute and Chronic Captopril, but Not Prazosin or Nifedipine, Normalize Alterations in Adrenergic Intracellular Ca2+ Handling Observed in the Mesenteric Arterial Tree of Spontaneously Hypertensive Rats
J. Pharmacol. Exp. Ther., April 1, 2005; 313(1): 359 - 367.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
E. N.T.P. Bakker, C. L. Buus, J. A.E. Spaan, J. Perree, A. Ganga, T. M. Rolf, O. Sorop, L. H. Bramsen, M. J. Mulvany, and E. VanBavel
Small Artery Remodeling Depends on Tissue-Type Transglutaminase
Circ. Res., January 7, 2005; 96(1): 119 - 126.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. D. Robinson, L. E. Reynolds, L. Wyder, D. J. Hicklin, and K. M. Hodivala-Dilke
{beta}3-Integrin Regulates Vascular Endothelial Growth Factor-A-Dependent Permeability
Arterioscler. Thromb. Vasc. Biol., November 1, 2004; 24(11): 2108 - 2114.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
E. L. Schiffrin and R. M. Touyz
From bedside to bench to bedside: role of renin-angiotensin-aldosterone system in remodeling of resistance arteries in hypertension
Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H435 - H446.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. E. Mabrouk, Q. N. Diep, K. Benkirane, R. M. Touyz, and E. L. Schiffrin
SAM68: a downstream target of angiotensin II signaling in vascular smooth muscle cells in genetic hypertension
Am J Physiol Heart Circ Physiol, May 1, 2004; 286(5): H1954 - H1962.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
G. M. London, R. G. Asmar, M. F. O'Rourke, M. E. Safar, and REASON Project Investigators
Mechanism(s) of selective systolic blood pressure reduction after a low-dose combination of perindopril/Indapamide in hypertensive subjects: comparison with atenolol
J. Am. Coll. Cardiol., January 7, 2004; 43(1): 92 - 99.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
A. Hartner, N. Cordasic, B. Klanke, U. Muller, R. B. Sterzel, and K. F. Hilgers
The {alpha}8 Integrin Chain Affords Mechanical Stability to the Glomerular Capillary Tuft in Hypertensive Glomerular Disease
Am. J. Pathol., March 1, 2002; 160(3): 861 - 867.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
R. M. Touyz, X.-H. Wu, G. He, S. Salomon, and E. L. Schiffrin
Increased Angiotensin II-Mediated Src Signaling via Epidermal Growth Factor Receptor Transactivation Is Associated With Decreased C-Terminal Src Kinase Activity in Vascular Smooth Muscle Cells From Spontaneously Hypertensive Rats
Hypertension, February 1, 2002; 39(2): 479 - 485.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
G. Cohuet, P. Challande, M. Osborne-Pellegrin, S. M. Arribas, A. Dominiczak, H. Louis, S. Laurent, and P. Lacolley
Mechanical Strength of the Isolated Carotid Artery in SHR
Hypertension, November 1, 2001; 38(5): 1167 - 1171.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
H. D. Intengan and E. L. Schiffrin
Vascular Remodeling in Hypertension: Roles of Apoptosis, Inflammation, and Fibrosis
Hypertension, September 1, 2001; 38(3): 581 - 587.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
H. Bouillier, E. Samain, C. Rucker-Martin, J.-F. Renaud, M. Safar, and G. Dagher
Effect of Extracellular Matrix Elements on Angiotensin II-Induced Calcium Release in Vascular Smooth Muscle Cells From Normotensive and Hypertensive Rats
Hypertension, June 1, 2001; 37(6): 1465 - 1472.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. M. Weis, J. L. Emery, K. D. Becker, D. J. McBride Jr, J. H. Omens, and A. D. McCulloch
Myocardial Mechanics and Collagen Structure in the Osteogenesis Imperfecta Murine (oim)
Circ. Res., October 13, 2000; 87(8): 663 - 669.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
H. D. Intengan and E. L. Schiffrin
Structure and Mechanical Properties of Resistance Arteries in Hypertension : Role of Adhesion Molecules and Extracellular Matrix Determinants
Hypertension, September 1, 2000; 36(3): 312 - 318.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
H. D. Intengan and E. L. Schiffrin
Vasopeptidase Inhibition Has Potent Effects on Blood Pressure and Resistance Arteries in Stroke-Prone Spontaneously Hypertensive Rats
Hypertension, June 1, 2000; 35(6): 1221 - 1225.
[Abstract] [Full Text] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
Jeong Bae Park, H. D Intengan, and E. L Schiffrin
Reduction of resistance artery stiffness by treatment with the AT1-receptor antagonist losartan in essential hypertension
Journal of Renin-Angiotensin-Aldosterone System, March 1, 2000; 1(1): 40 - 45.
[Abstract] [PDF]